<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00535548</url>
  </required_header>
  <id_info>
    <org_study_id>552</org_study_id>
    <nct_id>NCT00535548</nct_id>
  </id_info>
  <brief_title>Hematopoietic Stem Cell Therapy in Chronic Wounds Using a Pressure Sore Model</brief_title>
  <official_title>Effect of Hematopoietic Stem Cells in Chronic Wounds Using a Pressure Sore Model: A Pilot Study on Feasibility, Safety and Potential Effects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the study:

      Evaluation of feasibility, safety and potential effects of stem cells on chronic wounds using
      a pressure sore model.

      Clinical relevance:

        -  Accelerated healing of uncomplicated wounds

        -  Enhanced healing of complicated (chronic, non-healing) wounds

      Study design:

        -  Prospective controlled phase I/II study

        -  Cohort of 5 patients in pilot study, then reevaluation

      Patients:

      - Para- and tetraplegic patients with sacral pressure sores grade III-IVA according to the
      classification of Daniel and Seiler

      Methods:

      1. First surgical intervention:

        -  Radical debridement of pressure sore

        -  Bone marrow harvest from the iliac crest

        -  Isolation of hematopoietic stem cells, aiming to gain &gt; 1 mio. CD 34+ cells per patient
           under GMP conditions

           3. Stem cell therapy (after 2 days)

        -  Injection of stem cells in suspension (50'000 CD 34+ cells in 100 microliter saline per
           cm2 of wound surface) on one half of the total wound surface and cell-free saline on the
           other half as a control

           4. Second surgical intervention (after 3-4 weeks):

        -  Complete excision of the wound

        -  Closure of the defect by fasciocutaneous flap

           5. Evaluation of wound healing:

        -  Clinical

        -  3D laser imaging

        -  Histology

        -  Growth factor assay
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2007</start_date>
  <completion_date type="Anticipated">December 2007</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>feasibility, safety, efficacy</measure>
    <time_frame>1 yr</time_frame>
  </primary_outcome>
  <condition>Chronic Wounds</condition>
  <condition>Pressure Sores</condition>
  <condition>Hematopoietic Stem Cells</condition>
  <condition>Wound Healing</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Stem cell therapy</intervention_name>
    <description>Injection of a hematopoietic stem cell suspension (50'000 CD 34+ cells per microliter) into the wound (1 microliter per cm2 of wound surface)</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Para- or tetraplegic

          -  Sacral pressure sores

          -  Grade III-IV according to classification of Daniel and Seiler

        Exclusion Criteria:

          -  Diabetes mellitus

          -  Peripheral vascular disease

          -  Coronary artery disease

          -  Smoking

          -  Steroids and other immunosuppressive drugs

          -  Systemic autoimmune or rheumatoid diseases

          -  HIV

          -  Hepatitis B/C
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oliver Scheufler, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital Basel, Spitalstrasse 21, 4031 Basel, Switzerland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Oliver Scheufler, MD, PhD</last_name>
    <phone>+41-61-265 2525</phone>
    <email>oscheufler@gmx.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Swiss Paraplegic Center</name>
      <address>
        <city>Nottwil</city>
        <zip>6207</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Zweifel-Schlatter Mirjam, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 24, 2007</study_first_submitted>
  <study_first_submitted_qc>September 24, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2007</study_first_posted>
  <last_update_submitted>September 24, 2007</last_update_submitted>
  <last_update_submitted_qc>September 24, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 26, 2007</last_update_posted>
  <keyword>Chronic wounds</keyword>
  <keyword>Pressure sores</keyword>
  <keyword>Hematopoietic stem cells</keyword>
  <keyword>Wound healing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Pressure Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

